Phase I/IIa clinical trial of TB 403 in children and adolescents with medulloblastoma

Trial Profile

Phase I/IIa clinical trial of TB 403 in children and adolescents with medulloblastoma

Recruiting
Phase of Trial: Phase I/II

Latest Information Update: 20 Oct 2017

At a glance

  • Drugs THR 317 (Primary)
  • Indications Alveolar soft part sarcoma; Ewing's sarcoma; Medulloblastoma; Neuroblastoma
  • Focus Adverse reactions
  • Sponsors Oncurious
  • Most Recent Events

    • 20 Oct 2017 According to an ThromboGenics media release, the first 2 out of a planned 4 patient groups have now been recruited.
    • 02 May 2016 According to an Oncurious media release, first results from this trial are expected in 2017.
    • 02 May 2016 Status changed from not yet recruiting to recruiting, as reported in an Oncurious media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top